Largely because early testing of drugs occurred in males rather than females, for reasons discussed above, most commercial and hospital units devoted to human pharmacology testing were set up to deal with a unisex population. They ran one gender study at a time, usually male, in 1993. Sleeping and bathroom facilities in the units' dormitory accommodations did not provide for mixed gender groups. These were minor but not inexpensive attentions but were quickly adopted following the publication of the FDA Guidelines for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs (Fed Reg, 1993).
Was this article helpful?